215 FIRST STREET, CAMBRIDGE, MA
News, Articles of Incorporation, Material Contracts
Earnings Release
To Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio
News
Announces First Quarter 2025 Financial Results and Highlights Pipeline and Business Updates
Annual Report to Security Holders
Material disclosure
Announces Fourth Quarter and Full Year 2024 Financial Results and Highlights Pipeline
Q2
Q1
FY 2023
Q3
Notice of Suspension of Duty to File Reports
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Schedule 14D-9C Solicitation/Recommendation Statement Communication
S-3ASR
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Automatic Shelf Registration Statement
S-8 POS